ATE198624T1 - Expression von albumin in hefe - Google Patents

Expression von albumin in hefe

Info

Publication number
ATE198624T1
ATE198624T1 AT95921063T AT95921063T ATE198624T1 AT E198624 T1 ATE198624 T1 AT E198624T1 AT 95921063 T AT95921063 T AT 95921063T AT 95921063 T AT95921063 T AT 95921063T AT E198624 T1 ATE198624 T1 AT E198624T1
Authority
AT
Austria
Prior art keywords
pct
yeast
albumin
expression
sec
Prior art date
Application number
AT95921063T
Other languages
English (en)
Inventor
Patricia Carol Wood
Alan Victor Quirk
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Application granted granted Critical
Publication of ATE198624T1 publication Critical patent/ATE198624T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95921063T 1994-06-07 1995-06-07 Expression von albumin in hefe ATE198624T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9411356A GB9411356D0 (en) 1994-06-07 1994-06-07 Yeast strains
PCT/GB1995/001317 WO1995033833A1 (en) 1994-06-07 1995-06-07 Yeast strains

Publications (1)

Publication Number Publication Date
ATE198624T1 true ATE198624T1 (de) 2001-01-15

Family

ID=10756304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95921063T ATE198624T1 (de) 1994-06-07 1995-06-07 Expression von albumin in hefe

Country Status (14)

Country Link
US (1) US5783423A (de)
EP (1) EP0764209B1 (de)
JP (1) JP3667339B2 (de)
KR (1) KR100380532B1 (de)
AT (1) ATE198624T1 (de)
AU (1) AU698319B2 (de)
CA (1) CA2190373C (de)
DE (1) DE69519856T2 (de)
DK (1) DK0764209T3 (de)
ES (1) ES2156602T3 (de)
GB (2) GB9411356D0 (de)
GR (1) GR3035568T3 (de)
PT (1) PT764209E (de)
WO (1) WO1995033833A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US6274305B1 (en) 1996-12-19 2001-08-14 Tufts University Inhibiting proliferation of cancer cells
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
US6258559B1 (en) * 1999-03-22 2001-07-10 Zymogenetics, Inc. Method for producing proteins in transformed Pichia
EP1183385B1 (de) 1999-05-21 2006-07-19 Cargill Dow LLC Methoden und materialien zur synthese von organischen produkten
US6926898B2 (en) 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
EP1363992A1 (de) * 2001-02-26 2003-11-26 DSM IP Assets B.V. Verfahren zur steigerung der intrazelluläre glutamatkonzentration in hefe
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
EP1391510B1 (de) 2001-05-29 2007-09-12 Asahi Glass Company Ltd. Verfahren zur konstruktion eines wirts und herstellungsverfahren für fremdprotein
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
CA2841097A1 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin and g-csf fusion proteins
WO2003059934A2 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
US20060122374A1 (en) 2002-02-07 2006-06-08 Peter Mertins Albumin-fused anti-angiogenesis peptides
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
GB0224082D0 (en) * 2002-10-16 2002-11-27 Celltech R&D Ltd Biological products
US9057061B2 (en) 2003-12-23 2015-06-16 Novozymes Biopharma Dk A/S Gene expression technique
GB0329681D0 (en) * 2003-12-23 2004-01-28 Delta Biotechnology Ltd Gene expression technique
GB0329722D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
EP2330200B1 (de) 2004-12-23 2017-04-05 Albumedix A/S Genexpressionstechnik
DK2046826T3 (da) 2006-07-24 2011-10-24 Biorexis Pharmaceutical Corp Exendin-fusionsproteiner
WO2008019368A2 (en) * 2006-08-07 2008-02-14 Teva Biopharmaceuticals Usa, Inc. Albumin-insulin fusion proteins
EP2594583A1 (de) 2007-08-08 2013-05-22 Novozymes Biopharma DK A/S Transferrinvarianten und Konjugate
US20110294988A1 (en) 2009-02-06 2011-12-01 Novozymes Bio Pharma DK A/S Purification Process
SG172789A1 (en) 2009-02-11 2011-08-29 Novozymes Biopharma Dk As Albumin variants and conjugates
WO2014138371A1 (en) 2013-03-06 2014-09-12 Glaxosmithkline Llc Host cells and methods of use
CA2919327C (en) 2013-08-09 2022-06-21 Novozymes A/S Reducing content of hexenuronic acids in cellulosic pulp
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent

Also Published As

Publication number Publication date
JPH10501123A (ja) 1998-02-03
US5783423A (en) 1998-07-21
GB2302329B (en) 1998-04-29
WO1995033833A1 (en) 1995-12-14
DE69519856T2 (de) 2001-07-19
KR100380532B1 (ko) 2004-03-24
EP0764209A1 (de) 1997-03-26
PT764209E (pt) 2001-05-31
DE69519856D1 (de) 2001-02-15
CA2190373C (en) 2003-01-07
GB9411356D0 (en) 1994-07-27
CA2190373A1 (en) 1995-12-14
JP3667339B2 (ja) 2005-07-06
ES2156602T3 (es) 2001-07-01
GB2302329A (en) 1997-01-15
AU698319B2 (en) 1998-10-29
GR3035568T3 (en) 2001-06-29
AU2626295A (en) 1996-01-04
DK0764209T3 (da) 2001-03-19
EP0764209B1 (de) 2001-01-10
GB9622229D0 (en) 1996-12-18

Similar Documents

Publication Publication Date Title
DE69519856D1 (de) Expression von albumin in hefe
PT749478E (pt) Estirpes de levedura e albuminas modificadas
DE69534995D1 (de) Varianten von antigenen des menschlichen papillomvirus
FI960309L (fi) Neisseria meningitidis, B-ryhmän ulkomembraanin poriiniproteiinien korkean tason ilmentäminen, puhdistaminen ja uudelleenlaskostaminen
DE69325794D1 (de) Humanes serum albumin, herstellung und verwendung
DK0769020T3 (da) Nye hIL-4-mutantproteiner som antagonister eller delvise agonister for det humane interleukin-4
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
NO971875D0 (no) Cathepsin 02 protease
NO974514D0 (no) Syntetisk HPV6/11 hydrud L1 DNA som koder for humant papillomavirus Type 11 L1-protein
ATE237633T1 (de) Analogen des keratinozytenwachstumfaktors
ATE181921T1 (de) Chromatographische isolierung von nucleinsäuren
BG102362A (en) New derivatives of amino acids, their preparation and application
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
MX9700244A (es) Utilizacion de un poliholosido en una composicion limpiadora o desmaquillante, y composicion que lo incluye.
ATE234614T1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
SE9400524D0 (sv) Energipreparat
DE69431603D1 (de) Oligopeptide hergeleitet von fragmenten des c-reaktiven proteins
AU637589B2 (en) Ancrod proteins, their production and use
GR930300003T1 (en) Inhibitor of proliferation of endothelial cells.
AU8919591A (en) Process for reactivating denatured protein
DE69323191D1 (de) Wasserlösliche retinoide
ATE328088T1 (de) Transketolase-verwandtes protein
DK0861233T3 (da) N-Beskyttede/N-substituerede beta-aminohydroxysulfonater
TR199800850T2 (xx) Kan� d�zenleyici bile�imler.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
EEIH Change in the person of patent owner